These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 35469557)
1. Defining the peak: Point prevalence of SARS-CoV-2 using randomised sampling. Wattiaux AL; May F; Allen T; Bladen T; Pery B; McHugh L; Slinko V; Sykes A; De Silva L; Bajra J; Andrews R; Khandaker G Commun Dis Intell (2018); 2022 Apr; 46():. PubMed ID: 35469557 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461 [TBL] [Abstract][Full Text] [Related]
4. Protocol for a winter sentinel surveillance program of notifiable respiratory viruses in Queensland. Ginige S; Firman E; Li YS; Soonarane Y; Smoll N; May F; Hunter I; Pery B; Macfarlane B; Bladen T; Allen T; Lennon M; Walker J; Slinko V; Stickley M; Khandaker G; Anuradha S; Wattiaux A PLoS One; 2022; 17(11):e0277895. PubMed ID: 36441699 [TBL] [Abstract][Full Text] [Related]
5. The Importance of Incorporating At-Home Testing Into SARS-CoV-2 Point Prevalence Estimates: Findings From a US National Cohort, February 2022. Qasmieh SA; Robertson MM; Rane MS; Shen Y; Zimba R; Picchio CA; Parcesepe AM; Chang M; Kulkarni SG; Grov C; Nash D JMIR Public Health Surveill; 2022 Dec; 8(12):e38196. PubMed ID: 36240020 [TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022. Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466 [TBL] [Abstract][Full Text] [Related]
8. Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022. Stefanelli P; Trentini F; Petrone D; Mammone A; Ambrosio L; Manica M; Guzzetta G; d'Andrea V; Marziano V; Zardini A; Molina Grane' C; Ajelli M; Di Martino A; Riccardo F; Bella A; Sane Schepisi M; Maraglino F; Poletti P; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Merler S; ; ; ; Euro Surveill; 2022 Nov; 27(45):. PubMed ID: 36367013 [TBL] [Abstract][Full Text] [Related]
9. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics. Meo SA; Meo AS; Al-Jassir FF; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465 [TBL] [Abstract][Full Text] [Related]
10. Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention - New York City, November 18-December 20, 2021. Smith-Jeffcoat SE; Pomeroy MA; Sleweon S; Sami S; Ricaldi JN; Gebru Y; Walker B; Brady S; Christenberry M; Bart S; Vostok J; Meyer S; Seys S; Markelz A; Ditto N; Newbern V; Thomas FJ; Thomas D; Cabredo E; Kellner S; Brown VR; Tate JE; Kirking HL MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):238-242. PubMed ID: 35176004 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021. CDC COVID-19 Response Team MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670 [TBL] [Abstract][Full Text] [Related]
12. COVID-19-Related Symptoms during the SARS-CoV-2 Omicron (B.1.1.529) Variant Surge in Japan. Akaishi T; Kushimoto S; Katori Y; Sugawara N; Egusa H; Igarashi K; Fujita M; Kure S; Takayama S; Abe M; Kikuchi A; Ohsawa M; Ishizawa K; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Ishii T Tohoku J Exp Med; 2022 Sep; 258(2):103-110. PubMed ID: 36002251 [TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households - Four U.S. Jurisdictions, November 2021-February 2022. Baker JM; Nakayama JY; O'Hegarty M; McGowan A; Teran RA; Bart SM; Mosack K; Roberts N; Campos B; Paegle A; McGee J; Herrera R; English K; Barrios C; Davis A; Roloff C; Sosa LE; Brockmeyer J; Page L; Bauer A; Weiner JJ; Khubbar M; Bhattacharyya S; Kirking HL; Tate JE MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):341-346. PubMed ID: 35238860 [TBL] [Abstract][Full Text] [Related]
14. The epidemiology of the COVID-19 pandemic in the small, low-resource country of Timor-Leste, January 2020 - June 2022. Niha MA; Draper AD; Viegas ODS; de Araujo RM; Joao JC; da Silva E; Barreto I; Sarmento N; Oakley T; Machado FN; Fancourt NS; Marr I; Dos Santos Fernandes LN; Martins N; Arkell P; Tilman AJ; Dingle B; Freitas CC; Bhowmick PS; Sheridan S; Howden BP; Yan J; Francis JR; Martins N Commun Dis Intell (2018); 2023 Jan; 47():. PubMed ID: 36654501 [TBL] [Abstract][Full Text] [Related]
15. PCR performance in the SARS-CoV-2 Omicron variant of concern? Metzger CMJA; Lienhard R; Seth-Smith HMB; Roloff T; Wegner F; Sieber J; Bel M; Greub G; Egli A Swiss Med Wkly; 2021 Dec; 151():w30120. PubMed ID: 34909869 [TBL] [Abstract][Full Text] [Related]
16. The Emergence of SARS-CoV-2 Variant(s) and Its Impact on the Prevalence of COVID-19 Cases in the Nabatieh Region, Lebanon. Noureddine FY; Chakkour M; El Roz A; Reda J; Al Sahily R; Assi A; Joma M; Salami H; Hashem SJ; Harb B; Salami A; Ghssein G Med Sci (Basel); 2021 Jun; 9(2):. PubMed ID: 34199617 [No Abstract] [Full Text] [Related]
17. Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021. Espenhain L; Funk T; Overvad M; Edslev SM; Fonager J; Ingham AC; Rasmussen M; Madsen SL; Espersen CH; Sieber RN; Stegger M; Gunalan V; Wilkowski B; Larsen NB; Legarth R; Cohen AS; Nielsen F; Lam JUH; Lavik KE; Karakis M; Spiess K; Marving E; Nielsen C; Wiid Svarrer C; Bybjerg-Grauholm J; Olsen SS; Jensen A; Krause TG; Müller L Euro Surveill; 2021 Dec; 26(50):. PubMed ID: 34915977 [TBL] [Abstract][Full Text] [Related]
18. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
19. Self-collection and pooling of samples as resources-saving strategies for RT-PCR-based SARS-CoV-2 surveillance, the example of travelers in French Polynesia. Aubry M; Teiti I; Teissier A; Richard V; Mariteragi-Helle T; Chung K; Deen F; Paoaafaite T; Cao-Lormeau VM PLoS One; 2021; 16(9):e0256877. PubMed ID: 34473769 [TBL] [Abstract][Full Text] [Related]